ישראל - עברית - Ministry of Health

eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.

ישראל - עברית - Ministry of Health

eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.

ישראל - עברית - Ministry of Health

תעשיות חלאבין בעמ - לחותן

ישראל - עברית - Ministry of Health

neopharm scientific ltd - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin

ישראל - עברית - Ministry of Health

eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin

ישראל - עברית - Ministry of Health

תעשיות חלאבין בעמ - ניקוי העור

ישראל - עברית - Ministry of Health

תעשיות חלאבין בעמ - הזנת העור

ישראל - עברית - Ministry of Health

תעשיות חלאבין בעמ - הזנת העור

ישראל - עברית - Ministry of Health

תעשיות חלאבין בעמ - לחות לעור

ישראל - עברית - Ministry of Health

תעשיות חלאבין בעמ - לחות לעור